PRISMA Checklist – Challenges in the Market Access of Regenerative Medicines, and Implications for Manufacturers and Decision-Makers: A Systematic Review
Supplemental Table 1. Treatment Patterns after Index Line for the Anti-programmed Cell Death-1-treated Patients with Advanced Melanoma Treated with a BRAF Therapy in the Index Line or Pri
Supplementary Figure 1: Overview of the data analysis pipeline Supplementary Figure 2: Volcano plots showing differentially expressed (DE) genes between HC and RR in CD4, CD8, C
Aim: To explore the expression profiles of lncRNAs and identify novel lncRNAs as biomarkers for early diagnosis and therapy of hepatocellular carcinoma (HCC). Materials & methods: Expression pr
